Related Experiment Video

Updated: Jun 22, 2026

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo
08:53

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

Published on: January 10, 2025

[Erythropoietin in patients with chronic heart failure]

N A Makarova, I I Shaposhnik, Iu M Zakharov

    Klinicheskaia Meditsina
    |May 28, 2009
    PubMed

    Insights

    This study found that anemia in chronic cardiac failure (CCF) patients stimulates erythropoietin production. Anemia is linked to heart changes and impacts red blood cell characteristics and iron metabolism.

    Area of Science:

    • Cardiology
    • Hematology
    • Biochemistry

    Background:

    • Chronic cardiac failure (CCF) is often associated with anemia.
    • Erythropoietin (EPO) plays a crucial role in red blood cell production and is influenced by oxygen levels and inflammation.
    • Iron metabolism is critical for erythropoiesis and can be dysregulated in chronic diseases.

    Purpose of the Study:

    • To investigate the relationship between serum erythropoietin levels, cardiac function, red blood cell parameters, and iron metabolism in patients with ischemic chronic cardiac failure.
    • To explore the factors influencing erythropoietin production in the context of heart failure.

    Main Methods:

    • Study included 77 patients with ischemic CCF and 13 healthy controls.
    • Analyses included peripheral blood counts, serum iron, iron-binding capacity, creatinine clearance, erythropoietin, and TNF-alpha levels.
    • Echocardiography (echoCG) was used to assess cardiac structure and function.
    • Patients were stratified into three groups based on serum erythropoietin levels.

    Main Results:

    • A significant relationship was identified between anemia, myocardial structural-functional changes, and erythropoietin production in CCF patients.
    • Anemia was found to act as an additional stimulus for erythropoietin biosynthesis.
    • Elevated erythropoietin levels correlated with the degree of heart involvement and altered red blood cell characteristics.

    Conclusions:

    • Anemia in chronic cardiac failure is closely linked to cardiac dysfunction and influences erythropoietin production.
    • Erythropoietin levels serve as an indicator of the interplay between cardiac health, anemia, and iron status in CCF.
    • Understanding these relationships can inform therapeutic strategies for managing anemia in heart failure patients.

    Related Concept Videos

    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    Erythropoiesis01:14

    Erythropoiesis

    Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
    Erythropoiesis01:14

    Erythropoiesis

    Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
    Factors Affecting Erythropoiesis01:24

    Factors Affecting Erythropoiesis

    The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
    Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
    EPO then...
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...